| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |